Agilent debuts immune cell analysis platform

By The Science Advisory Board staff writers

February 17, 2021 -- Agilent Technologies has debuted its Seahorse extracellular flux (XF) HS miniplate that provides improved immune cell metabolic analysis.

Specifically designed for the Agilent's Seahorse XF HS mini analyzer, the mini platform analyzes mitochondrial respiration, glycolysis, and adenosine triphosphate (ATP) production in live cells in real-time. The platform is ideal for performing energy metabolism measurements ex vivo, according to the company. With these measurements, researchers can better understand cell health, function, and signaling.

If you like this content, please share it with a colleague!

Related Reading

Agilent offers new flow cytometers
Agilent Technologies has launched a new product offering, the Agilent NovoCyte Penteon, a flow cytometer with five lasers and up to 30 fluorescence channels.

Agilent expands molecule manufacturing capacity
Agilent Technologies said that it's expanding its Frederick, CO-based production facility to more than double its current capacity for developing the...

Agilent unveils new handheld raw material ID system
Agilent Technologies has launched Vaya Raman, a handheld raw material identity verification system for pharmaceutical manufacturers.

Agilent launches new microarrays for cytogenetic testing
Agilent Technologies has unveiled three new microarrays to support pre- and postnatal research by cytogenetic laboratories.

Agilent to fund biotherapy incubator in India
Agilent Technologies has announced a partnership with the Indian Institute of Technology Delhi to advance biotherapeutic research in the country.